211054-02-3 Usage
Uses
Used in Medicinal Chemistry:
(R)-2-AMINOHEX-5-YNOIC ACID is used as a building block in the synthesis of new compounds for medicinal chemistry, leveraging its structural features to create entities with potential therapeutic applications.
Used in Drug Discovery:
In the field of drug discovery, (R)-2-AMINOHEX-5-YNOIC ACID is utilized as a key component in the design and development of innovative pharmaceuticals, aiming to address unmet medical needs through its incorporation into new molecular frameworks.
Used in Materials Science:
(R)-2-AMINOHEX-5-YNOIC ACID is employed in the development of new materials, capitalizing on its chemical properties to contribute to advancements in material properties and functions.
Used in Biological Research:
In biological research, (R)-2-AMINOHEX-5-YNOIC ACID is used as a tool to study biological processes and signaling pathways, providing insights into the mechanisms of various biological systems and potentially leading to new therapeutic targets.
Check Digit Verification of cas no
The CAS Registry Mumber 211054-02-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,1,0,5 and 4 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 211054-02:
(8*2)+(7*1)+(6*1)+(5*0)+(4*5)+(3*4)+(2*0)+(1*2)=63
63 % 10 = 3
So 211054-02-3 is a valid CAS Registry Number.
211054-02-3Relevant articles and documents
A Biocatalytic Route to Enantiomerically Pure Unsaturated α-H-α-Amino Acids
Wolf, Larissa B.,Sonke, Theo,Tjen, Kim C. M. F.,Kaptein, Bernard,Broxterman, Quirinus B.,Schoemaker, Hans E.,Rutjes, Floris P. J. T.
, p. 662 - 674 (2007/10/03)
A set of both enantiomeric forms of non-proteinogenic, unsaturated α-H-α-amino acids was efficiently synthesized using a biocatalytic pathway. This route involved the straightforward synthesis of the required unsaturated amino acid amides, followed by resolution with an aminopeptidase present in Pseudomonas putida ATCC 12633 and/or a genetically modified organism, leading to the (S)-acids and (R)-amides. Undesired amino acid racemase activity was identified in the wild-type strain, which was absent in the newly developed organism. The (R)-amides were hydrolyzed under mild conditions using an amidase present in whole cells from Rhodococcus erythropolis NCIMB 11540 to the (R)-acids. The viability of this procedure was demonstrated with the multi-gram synthesis of a variety of unsaturated amino acids in excellent enantiopurity.
